Clinical Trial Update: Study to Evaluate Efficacy and Safety of Two Drug Regimens in Subjects With Moderate to Severe Crohn's Disease [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating two regimens for moderate to severe Crohn's disease has completed and results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Snippet

Sponsor: AbbVie | Conditions: Crohn's Disease | Phase 3 | Status: COMPLETED | Results posted: 2021-02-18